Survival after Stereotactic Radiosurgery in the Era of Targeted Therapy: Number of Metastases No Longer Matters

Randomised control trial data support the use of stereotactic radiosurgery (SRS) in up to 4 brain metastases (BMs), with non-randomised prospective data complementing this for up to 10 BMs. There is debate in the neuro-oncology community as to the appropriateness of SRS in patients with >10 BMs. We...

Descrizione completa

Dettagli Bibliografici

Autori principali:	James de Boisanger, Martin Brewer, Matthew W. Fittall, Amina Tran, Karen Thomas, Sabine Dreibe, Antonia Creak, Francesca Solda, Jessica Konadu, Helen Taylor, Frank Saran, Liam Welsh, Nicola Rosenfelder
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	MDPI AG 2024-05-01
Serie:	Current Oncology
Soggetti:	stereotactic radiosurgery brain metastases number of metastases
Accesso online:	https://www.mdpi.com/1718-7729/31/6/228
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!